BCL2L11 and breast cancer: Similarly, the pro-apoptotic protein Bim, another downstream target of FOXO3a was increased in both breast cancer-lines cells at 24 h after vernodalin treatment (6.25, 9.5 and 12 μg/ml) as compared with untreated control cells Fig. 1a and b.